epigallocatechin gallate has been researched along with Bacterial Infections, Gram-Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, HH; Min, SU; Suh, DH; Thiboutot, DM; Yoon, JY | 1 |
1 trial(s) available for epigallocatechin gallate and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.
Topics: Acne Vulgaris; AMP-Activated Protein Kinases; Antioxidants; Apoptosis; Catechin; Cell Line, Transformed; Child; Dermatitis; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Lipogenesis; Male; NF-kappa B; Propionibacterium acnes; Sebum; Signal Transduction; Transcription Factor AP-1; Treatment Outcome | 2013 |